blog

When it Comes to Patient Data, Think First About the Patient

By BBK Worldwide on Thu, Aug 9, 2018 | 1 min read

 

Experts across the healthcare industry agree that patients should be able to easily access their medical data. While this sentiment is shared among key industry stakeholders, the ideas of “consumer centricity”, and how researchers specifically stand to benefit from delivering patient data, are popular talking points among experts in our industry.

Topics: clinical research, clinical trials, Pharma15, patient data

Agree or Disagree: We are Past the Era of Hype in Digital Health

By BBK Worldwide on Tue, Aug 7, 2018 | 1 min read

When it comes to digital health, do you believe that we are past the era of hype and into the era of adoption? Is there a degree of skepticism that still inhibits the wider adoption of digital health solutions in clinical research and healthcare?

Topics: Patient Recruitment, digital health, Digital Platforms, Pharma15

Maximizing Digital Patient Engagement: A Four Step Process

By BBK Worldwide on Thu, Aug 2, 2018 | 1 min read

The idea of “digital patient engagement” continues to be one of the hottest topics in the healthcare industry, and according to BBK Worldwide director of innovation Erica Mercado, everyone defines this term in different ways. For instance, apps, wearables, and digital outreach and messaging are all tactics that can be effectively deployed to keep patients engaged. But for Erica, truly effective digital patient engagement amounts to more than the sum of its parts.

Topics: Patient Engagement, digital health, Patient Experience, Pharma15, Vlog

Expert Take: Regulations aren’t an Excuse. Healthcare is Still Behind in Mobile Tech Adoption.

By BBK Worldwide on Tue, Jul 31, 2018 | 1 min read

Even when we consider the strict regulations inherent to the healthcare industry, we are still years behind where we should be with regard to the adoption of mobile health technologies. Just look to other highly regulated sectors, like banking and finance; we see that adoption of mobile technology in these industries is much more established.

Topics: mHealth, digital health, Pharma15

Amazon and PillPack: Disruptions and Innovations on the Horizon

By BBK Worldwide on Thu, Jul 26, 2018 | 1 min read

There is no doubt that Amazon’s recent acquisition of PillPack – the independent pharmacy and medication distribution system – has major implications not only for the clinical research industry, but the healthcare industry at-large. We asked BBK Worldwide president Matt Kibby to weigh in on Amazon’s foray into the pharmaceutical space. 

Topics: Pharma15, Vlog

Experts Debate: Is the Future Now for Mobile Technology and the Patient Experience?

By BBK Worldwide on Thu, Jul 12, 2018 | 1 min read

With regard to the adoption and use of digital health solutions in clinical R&D, where are we as an industry? In our latest Pharma15 Live! debate, BBK Worldwide founding principal Bonnie A. Brescia posed this question to the panel of industry experts. Justin Johnson, CEO of Biotaware, answered in no uncertain terms: “[the industry] is five to eight years behind where it should be.” Do you agree?

Topics: Pharma15, Most Viewed

Agree or Disagree: Qualified Referrals Keep Sites Engaged

By BBK Worldwide on Wed, May 2, 2018 | 1 min read

 

While sites should be held accountable for processing the referrals that are generated from clinical trial advertising, it is very important that these referrals are qualified so that sites are not wasting their time. Therefore, generating highly qualified referrals is the number one contributing factor to site engagement.

Do you agree? Disagree? Watch the latest clip from our first episode of Pharma15 Live! and leave a comment below.

Topics: Pharma15

Agree or Disagree: Clinical Trial Sites Must Invest in Branding

By BBK Worldwide on Mon, Apr 30, 2018

There is a difference between “advertising” to generate referrals for clinical studies and “branding” for clinical trial sites. To remain relevant in a changing media landscape, sites must allocate part of their advertising budget to invest in branding. Do you agree? Disagree? Leave a comment below.

Topics: Pharma15

Agree or Disagree: Regulatory Bodies Need Social Media Training

By BBK Worldwide on Wed, Apr 25, 2018

If regulatory bodies are reviewing advertising and content for digital channels, like social media, should they receive education to understand how these channels work?

Check out the latest clip from our first Pharma15 Live! debate. Do you agree? Disagree? Leave a comment below.

Topics: Social Media, clinical research, Pharma15

Clinical Trial Advertising: Is It Just About Referrals?

By BBK Worldwide on Mon, Apr 23, 2018 | 1 min read

When it comes to direct-to-consumer advertising for clinical trials, is it just about generating referrals for sites? Or is the quality of the referral more important than quantity?

Watch this clip from our first Pharma15 Live! debate between industry experts. Do you agree or disagree? Comment below!

Topics: Pharma15

 
Subscribe To Our Blog